Initial Data from Shire Collaboration Identifies Key Biomarkers That Affect Bleeding Patterns, Response to Treatment for Hemophilia A
01 déc. 2018 12h00 HE
|
Shire Pharmaceuticals Group
Initial Data from Shire Collaboration Identifies Key Biomarkers That Affect Bleeding Patterns, Response to Treatment for Hemophilia A Data from iPATH Collaboration to be presented at the American...
Shire plc : Rule 2.9 Announcement
03 août 2018 02h01 HE
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Rule 2.9 Announcement
02 août 2018 02h01 HE
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Total voting rights
01 août 2018 05h01 HE
|
Shire Pharmaceuticals Group
Total Voting Rights August 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and...
Shire plc : Half-year Report
01 août 2018 02h01 HE
|
Shire Pharmaceuticals Group
Half-yearly Report August 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG), ("Shire" / the "Company"/ the "Group") in accordance with the Financial Conduct Authority's Disclosure Guidance and...
Shire plc : Rule 2.9 Announcement
01 août 2018 02h01 HE
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : 2nd Quarter Results
31 juil. 2018 07h01 HE
|
Shire Pharmaceuticals Group
Shire Delivers Q2 2018 Product Sales Growth of 6% and Continued Regulatory and Pipeline Progress Product sales grew to $3.8 billion driven by Immunology, recently launched products,...
Shire plc : Miscellaneous
30 juil. 2018 02h01 HE
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Rule 2.9 Announcement
26 juil. 2018 02h00 HE
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Director Declaration
25 juil. 2018 10h31 HE
|
Shire Pharmaceuticals Group
Director Declaration July 25, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces that Steven Gillis, Non-Executive Director of the Company, is a Non-Executive Director of...